News: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

46.28USD
24 Apr 2014
Price Change (% chg)

$-0.49 (-1.05%)
Prev Close
$46.77
Open
$47.32
Day's High
$47.66
Day's Low
$45.00
Volume
1,334,049
Avg. Vol
1,358,521
52-wk High
$54.25
52-wk Low
$26.47

Search Stocks
Select another date:

Tue, Apr 8 2014

Alkermes to seek schizophrenia drug approval after trial success

- Alkermes Plc said it planned to seek U.S. marketing approval for its experimental drug to treat the symptoms of schizophrenia after it succeeded in a late-stage study, sending the company's shares up as much as 11 percent.

UPDATE 3-Alkermes to seek schizophrenia drug approval after trial success

* To apply for U.S. marketing approval in the third quarter

CORRECTED-UPDATE 1-Alkermes' schizophrenia drug meets main goal of late-stage study

(Corrects to remove paragraphs referring to Alzheimer's disease. Alkermes' drug is not used to treat Alzheimer's)

Alkermes' schizophrenia drug meets main goal of late-stage study

April 8 - Alkermes Plc said its experimental drug to treat the symptoms of schizophrenia met the main goal of reducing the severity of symptoms of the disease in a late-stage study.

Select another date:
Search Stocks